SyVento BioTech is proud to announce our participation in the 4th LNP Formulation & Process Development Summit in Boston– the premier global forum dedicated exclusively to Lipid Nanoparticle (LNP) innovation!
As a company at the forefront of advanced drug delivery technologies, we cannot miss the opportunity to attend this significant event. SyVento BioTech specializes in the design, development, and manufacturing of LNP formulations, enabling precise and efficient delivery of RNA, DNA, CRISPR, small molecules, proteins and peptides. With our deep scientific expertise and proprietary platforms, we’re actively shaping the future of innovative medicines including next-generation mRNA-based drug products.
